LUMIBIRD's 2026 Half-Year Results: Stable Growth and Promising Outlook

The Lumibird Group, a specialist in laser technologies, announced a 7.4% increase in revenue for the first half of 2026, reaching €114.7 million. The Photonics division was the main driver of this growth, with a 15.3% increase in revenue and a 20.2% rise in EBITDA, reaching a margin of 16.5%.

Despite cost pressures due to the geopolitical situation, net income increased by 4.5%, reaching €5.1 million. The improvement in operating cash flow generation to €11.1 million, compared to €7.7 million last year, is particularly noteworthy.

The sale of Lumibird Medical, planned for the end of 2026, should allow the group to focus entirely on photonics, thus strengthening its strategic position in this market.